Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

April 18, 2023

Primary Completion Date

August 22, 2025

Study Completion Date

September 11, 2025

Conditions
Alzheimer's Disease
Interventions
DRUG

50561 high dose

study drug

DRUG

50561 low dose

study drug

DRUG

Placebo

Non-active study drug

Trial Locations (12)

100053

Xuanwu Hospital, Capital Medical University, Beijing

Unknown

Beijing Anding Hospital, Capital Medical University, Beijing

Beijing Friendship Hospital, Capital Medical University, Beijing

Beijing Tiantan Hospital, Capital Medical University, Beijing

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou

Heilongjiang Provincial Hospital of Traditional Chinese Medicine, Haerbin

Wuhan Union Hospital of China, Wuhan

The Second Affiliated Hospital of Nanjing Medical University, Nanjing

The First affiliated hospital of SOOCHOW university, Suzhou

The First Bethune Hospital of Jilin University, Changchun

Tianjin Huanhu Hospital, Tianjin

Sir Run Run Shaw Hospital, Hangzhou

All Listed Sponsors
lead

Beijing Joekai Biotechnology LLC

INDUSTRY